| Description | African Green monkey has long been one of the most important non-human primate models for biomedical research which is close to Rhesus monkey. This product is collected from African Green monkeys Veins or arteries tissue. The sample is negative for Herpes B Virus, retroviruses, SIV, SRV, & STLV. It African Green monkey has long been one of the most important non-human primate models for biomedical research which is close to Rhesus monkey. This product is collected from African Green monkeys Veins or arteries tissue. The sample is negative for Herpes B Virus, retroviruses, SIV, SRV, & STLV. It can be applied for life science laboratory or biochemical experiment such as PCR, Western blot, immunoprecipitation, immunofluorescent flow cytometry.... Read More | Anaerostipes is a Gram positive and anaerobic bacterial genus from the family of Lachnospiraceae. Anaerostipes occurs in the human gut. It may protect against colon cancer in humans by producing butyric acid. | This product GTTS-WK5967MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the CD40 protein. This product can be used in -related researches. | This product is a 113.7 kDa Human DSG1 membrane protein expressed in HEK293. The protein is for research use only and is not approved for use in humans or in clinical diagnosis. | Recombinant Norovirus GII.4 Virus-like Particles (NoV GII.4 VLPs) are produced in Insect cell expression system, assembled with VP1 structure protein. VLP is mimicking the native 3D structure of viruses which can elicit strong immune responses. However, VLPs lack viral genomic material which makes Recombinant Norovirus GII.4 Virus-like Particles (NoV GII.4 VLPs) are produced in Insect cell expression system, assembled with VP1 structure protein. VLP is mimicking the native 3D structure of viruses which can elicit strong immune responses. However, VLPs lack viral genomic material which makes them non-infectious, unable to replicate and enhance the safety during manufacture and administration. NoV GII.4 VLPs can be used in the development of NoV GII.4 diagnostics and in vaccine development and R&D (including use as an immunogen).... Read More |